Unaudited results for period ended 31 August 2024

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241127:nRSa7409Na&default-theme=true

RNS Number : 7409N  Inqo Investments Limited  27 November 2024
Inqo Investments Limited

 

Unaudited Group Results for the half-year period ended 31 August 2024

 

CHAIRMAN AND CHIEF EXECUTIVE'S STATEMENT

Inqo Investments Limited ("Inqo" or "the Group") is a South African based
social impact company that invests in businesses that tackle poverty and
environmental challenges in Sub-Saharan Africa.

COMMENTARY

The Group remains in a strong financial position with total assets of
R234,859,780 and minimal debt.

The results for the half-year period under review showed revenue of R8,199,813
(August 2023: R7,366,899). The hospitality and tourism industry is
characterised by seasonal fluctuations, with the interim period aligning with
the off-peak season, which historically results in lower occupancy rates and
revenue. The Group generates 80% of its revenue from the hospitality and
tourism sector. The Group earned a profit after tax of R532,516 (August 2023:
loss after tax R4,069,070).

In April 2024, the company issued 1,854,646 new ordinary shares, raising gross
capital of R 29,984,428. This includes the conversion of two credit loan notes
of USD 1,000,000 and R 2,000,000 respectively into equity by the lenders
exercising their conversion rights.

In 2023, Inqo was awarded a US$4 million grant over three years to fund its
Conservation and Rural Enterprise (CARE) project in Uganda. To date, Inqo has
received US$3 million of this grant. During the period, the Group formalised
three CARE investments in Uganda, namely Flybox Budongo (BSF) Farm Limited,
Pabidi Lodge Budongo Limited and Empower Clean Cooking Limited.  In the
current period, grant funding utilised amounted to R5,143,989 (August 2023:
Rnil).

Whilst there has been no change in the company's shareholding in Spekboom
Trading (Pty) Limited, a shift in the voting rights has occurred. As a result,
the company has ceased consolidation and now recognises the investment under
the equity method.

FINANCIAL INFORMATION

The financial information set out in this announcement does not constitute
statutory financial statements. This financial information has been extracted
from Inqo's unaudited group financial statements for the half-year period
ended 31 August 2024.

 

FINANCIAL RESULTS

The unaudited financial results for the half-year period ended 31 August 2024
are as follows:

                                                                       Aug-24   Aug-23
                                                                       R'000    R'000
 Revenue                                                               8,200    7,367
 Profit/(Loss) for the year                                            533      (4,069)
 Earnings per share                                                    0.03     (0.27)

 Total Assets                                                          234,860  223,854

 Unutilised Grant Funding                                              41,620   34,404
 Total Liabilities excl Unutilised Grant Funding                       10,540   36,597

 Net Assets                                                            182,700  152,853
 Profit/(Loss) from operating activities includes the following items
 Grant income                                                          5,144    -
 Depreciation and amortisation                                         (1,102)  (1,605)
 Personnel Costs                                                       (2,524)  (2,855)
 Directors' Fees and Salaries                                          (648)    (486)
 Listing Expenses                                                      (486)    (373)
 Professional Fees                                                     (528)    (307)
 Reversal/(Raising) of impairment of loans: Four One                   181      (25)
 Re-instatement of impairment of loans: Spekboom Trading               (530)    -
 Fair value adjustment of the buffalo herd                             18       296

In August 2024, the directors of Inqo reviewed the valuation placed on all
income earning assets to ensure that they reflect their fair value.
Following the reviews, the directors are of the view that Group assets as
stated in the Statement of Financial Position are reflected at fair value.
The only non-South African company where Inqo held investments that required
assessment from a fair value adjustment perspective was Four One Financial
Services Limited. The company has struggled financially but managed to remain
operational, however in the process has defaulted on loan and interest
repayments.  For this reason, the loan including interest amounting to
R4,005,264 remains impaired in full.

INVESTEE COMPANIES: FINANCIAL, ENVIRONMENTAL AND SOCIAL PERFORMANCE COMMENTARY

Beyond the specific changes outlined below, there have been no other material
developments or significant events impacting the investee companies during the
period.

Kuzuko Lodge (Pty) Limited (South Africa)

After exiting the hotel management company approximately one year ago, Kuzuko
Lodge has implemented a focused strategy to improve operational efficiency and
increase revenue. These efforts have resulted in a turnaround, with a loss of
R4,013,271 in August 2023 shifting to a loss of R743,774 in August 2024. This
positive trajectory can be attributed to a combination of cost containment
measures and targeted marketing initiatives. The directors anticipate that
Kuzuko will continue to build on this momentum and achieve profitability by
the end of the year, particularly as the peak tourism season approaches.

 

CARE Investees

·   Flybox Budongo (BSF) Farm Limited (Uganda) forms part of the Uganda
CARE project. Inqo has partnered with Mana Biosystems Limited (United Kingdom)
(FlyBox UK) to implement the Black Soldier Fly project in Uganda.  The
purpose of insect farming is to upcycle organic waste into animal protein and
compost.  The business will initially sell larvae and eggs to farmers to grow
to maturity by feeding on market and organic waste. These larvae can then be
harvested for use as protein substitute in animal feed.  At reporting date,
Flybox UK had been commissioned to build modular insect farms due for delivery
in Uganda in December 2024.  No further business activity has commenced.

·     Pabidi Lodge Budongo Limited (Uganda) forms part of the Uganda
CARE project. Pabidi Lodge is currently under construction and it is expected
to open in May 2025. The lodge will be the only luxury accommodation offering
sustainable ecotourism to guests in the Budongo Forest. The Lodge will be
operated by Great Lakes Safaris, one of the leading tour operators in Uganda.
Great Lakes Safaris hold the sole conservancy in the Budongo Forest, an 825 sq
km forest that is home to more than 600 chimpanzees.  The founder and CEO of
Great Lake Safaris is the majority shareholder of Budongo-Eco Lodge Limited,
Inqo's joint venture partner. The site clearance and construction of the lodge
commenced during the reporting period.

·     Empower Clean Cooking Limited (Uganda) forms part of the Uganda
CARE project. Empower Clean Cooking Limited is a joint venture between Inqo
and East African Power Limited.  Empower Clean Cooking Limited will be
managed and operated by East Africa Power, a highly experienced renewable
energy developer and operator with hydro and solar plants in Rwanda, Uganda,
DRC, Zambia, Zimbabwe and Kenya. The objective of the company is to safeguard
the environment through providing clean cooking solutions to local
environments. The joint venture will manufacture biomass pellets for cooking
fuel as an alternative to wood and charcoal and to explore clean cooking
solutions for the local community.  The company has not commenced operations.

SUMMARY OF SOCIAL & ENVIRONMENTAL METRICS SINCE PROJECT COMMENCEMENT

·      Kuzuko Lodge

o  35,617 acres (14,414 hectares) of former farmland restored and protected
as a game reserve

o  70 km of game fencing erected

o  45 FTE staff at Kuzuko in standard housing with flush toilets, power,
water and solar panels

o  120 fixed term jobs

o  Conservation of 2 endangered species, 8 endangered species protected, 23
species introduced

o  Re-wilded 18 adult cheetahs with diverse genetics to bolster the
meta-population in southern Africa

·      Southlake Medical Centre

o  98,719 patient visits including 386 HIV patients receiving care and
counselling, 5,599 people receiving health education including through
community outreach, 217 safe deliveries, 205 surgeries, 2,000 cervical cancer
screens and 700+ HPV vaccinations

·      Kentegra

o  300 FTE and 26,000 contracted out-growers

·      Sanergy

o  1,000 FTE, 2,000 indirect jobs, 5,000 toilets serving 270,000 people in
Nairobi, Kisumu and Eldoret

·      Spekboom Trading

o  5,185 hectares degraded land planted with 30 million spekboom; 350 fixed
term jobs

STAFF

The directors would like to take this opportunity to thank all the operating
staff in the Group for their contribution and commitment to the Group's
objectives during this challenging time.

 
 

K.S
Tan
R.H Steyn

Chairman
                                        Chief Financial
Officer

Issued on: 27 November 2024

 Enquiries

 

 Inqo Investments Limited              Tel: +27 834249880
 Robyn Steyn, Chief Financial Officer  Email: finance@inqo.co.za (mailto:finance@inqo.co.za)

 Hobart Capital Markets LLP
 AQSE Corporate Adviser and Broker     Tel: +44 (0)20 7070 5665
 Dr Wang Chong                         Email: wang.chong@hobartcapital.com

Statements of Financial Position

                                                                                    Group

                                                   Group         Group              31 August

 Figures in R                                      31 August     29 February 2024   2023 -

                                                   2024                             restated*

 Assets
 Non-current assets

 Property, plant and equipment *                   150,695,290   151,980,926        152,842,048
 Right-of-use assets                                             68,147             152,975
 Intangible assets                                 339           840                1,340
 Investment in joint ventures and associates       7,867,661
 Other investments                                 7,179,889     7,306,227          9,134,004
 Total non-current assets *                        165,743,179   159,356,140        162,130,367
 Current assets
 Inventories                                       4,179,170     4,295,937          5,055,693
 Trade and other receivables                       3,550,837     6,059,424          3,858,133
 Biological assets                                 995,000       977,000            3,085,440
 Cash and cash equivalents                         60,391,594    43,771,590         49,724,635
 Total current assets                              69,116,601    55,103,951         61,723,901
 Total assets *                                    234,859,780   214,460,091        223,854,268

 

* - The donation of Spekboom plantings had been recognised as Other Income in
the interim report for the period ended 31 August 2023. This was not the final
accounting treatment in the audited annual financial statements for the year
ended 29 February 2024, and as such the 31 August 2023 interim comparatives
above have been corrected to follow the annual financial statements.

                                                                                                Group

                                                            Group            Group              31 August 2023 - restated*

 Figures in R                                               31 August 2024   29 February 2024

 Equity and liabilities
 Equity
 Ordinary share capital                                     81,858,155       72,584,925         72,584,925
 Share premium                                              108,296,468      87,585,270         87,585,270
 Accumulated loss *                                         (94,528,411)     (95,364,654)       (94,049,312)
 Revaluation reserve                                        86,693,347       86,693,347         86,693,347
 Total equity attributable to owners of the parent*         182,319,559      151,498,888        152,814,230
 Non-controlling interests                                  380,106          119,507            38,665
 Total equity*                                              182,699,665      151,618,395        152,852,895
 Liabilities
 Non-current liabilities
 Deferred tax liabilities                                   4,582,035        3,809,116          4,596,962
 Loans from related parties                                 1,614,127        3,423,672          4,599,458
 Other loans                                                                 18,931,500         18,590,000
 Total non-current liabilities                              6,196,162        26,164,288         27,786,420
 Current liabilities
 Trade and other payables                                   4,344,165        3,683,554          8,061,296
 Lease liabilities                                                           80,155             217,243
 Unutilised grant funding                                   41,619,788       32,846,571         34,404,005
 Bank overdraft                                                              67,128             532,409
 Total current liabilities                                  45,963,953       36,677,408         43,214,953
 Total liabilities                                          52,160,115       62,841,696         71,001,373
 Total equity and liabilities *                             234,859,780      214,460,091        223,854,268

 

Statements of Profit or Loss and Other Comprehensive Income

                                                                                                                                                                                                                         Group
 Group                                                                                                                                                                                                                   12 month      Group 6 month
 6 month                                                                                                                                                                                                                 period ended  period ended
 period ended                                                                                                                                                                                                            29 February   31 August 2023
 Figures in                                                                                                                                                                                                              2024          - restated*
 R
        31 August 2024

 Revenue                                                                                                                                         8,199,813                                                               20,610,801    7,366,899
 Cost of sales                                                                                                                                   (1,074,048)                                                             (2,421,823)   (1,049,896)
 Gross profit                                                                                                                                    7,125,765                                                               18,188,978    6,317,003
 Other income *

                                                                                                                                                 5,378,999                                                               3,630,200     279,996
 Personnel expenses                                                                                                                              (3,171,797)                                                             (6,996,171)   (3,340,548)
 Depreciation and amortisation                                                                                                                   (1,102,141)                                                             (2,936,964)   (1,605,019)
 Listing expenses                                                                                                                                (486,185)                                                               (933,451)     (372,904)
 Professional fees                                                                                                                               (528,209)                                                               (369,556)     (306,600)
 Provision for doubtful debts                                                                                                                    (160,321)                                                               (319,841)     (160,321)
 Impairment                                                                                                                                      181,457                                                                 (1,920,552)   (24,822)
 Reinstatement of loan impairment - Spekboom                                                                                                     (530,286)
 Other expenses                                                                                                                                  (5,966,543)                                                             (12,836,487)  (6,511,330)
 Profit/ (loss) from operating activities *                                                                                                      740,739                                                                 (4,493,844)   (5,724,545)
 Inventory write (down)/up                                                                                                                                                                                               (832,272)     8,000
 Fair value adjustment                                                                                                                           18,000                                                                  (1,811,980)   296,460
 Finance income                                                                                                                                  568,705                                                                 995,676       1,218,522
 Finance costs                                                                                                                                   (22,008)                                                                (167,020)     (85,531)
 Profit/ (loss) before tax*                                                                                                                      1,305,436                                                               (6,309,440)   (4,287,094)
 Income tax (expense)/ credit                                                                                                                    (772,920)                                                               1,005,869     218,024
 Profit/ (loss) for the period *                                                                                                                 532,516                                                                 (5,303,571)   (4,069,070)

                                                                                                                        Group
                                                                            Group                         12 month      Group 6 month
                                                                            6 month                       period ended  period ended
                                                                            period ended                  29 February   31 August 2023
 Figures in R                                                                             31 August 2024                2024            - restated*

 Profit/ (loss} for the period attributable to:
 Owners of Parent *                                                                       553,267                       (5,262,858)     (3,947,516)
 Non-controlling interest                                                                 (20,751)                      (40,713)        (121,554)
                                                                                                                        (5,303,571}

                                                                                          532,516                                       (4,069,070}

 Earnings per share from continuing and discontinuing operations
 attributable to owners of the parent during the period Basic earnings per
 share *

 Basic earnings/ (loss) per share *

                                                                                          0.03                          (0.36)          (0.27)

 Diluted earnings per share *

 Diluted earnings/ (loss) per share *                                                                                   (0.36)

                                                                                          0.03                                          (0.27)

 Total comprehensive income*                                                              532,516                       (5,303,571}     (4,069,070}

 Comprehensive income attributable to:
 Comprehensive income, attributable to owners of parent *                                 553,267                       (5,262,858)     (3,947,516)
 Comprehensive income, attributable to non-controlling interests                          (20,751)                      (40,713)        (121,554)
                                                                                                                        (5,303,571}

                                                                                          532,516                                       (4,069,070}

 

Statement of Cash Flows

 

                                                                                                     Group 12 month

                                                                                   Group 6 month     period ended    Group

                                                                                   period ended      29 February     6 month

                                                                                                                     period ended
 Figures in R                                                                      31 August 2024    2024            31 August 2023

 Net cash flows used in operations                                                 (1,013,582)       (11,800,817)    (4,901,289)
 Interest paid                                                                     (12,251)          (143,656)       (85,531)
 Interest received                                                                 1,013,664         995,676         1,218,522
 Net cash flows used in operating activities                                       (12,169)          (10,948,797)    (3,768,298)

 Cash flows from investing activities
 Cash flows from losing control of subsidiaries                                    (2,668)
 Cash flows used in obtaining control of subsidiaries or other businesses

                                                                                   (7,225,997)
 Proceeds from sales of property, plant and equipment                                                (17,103)        58,696
 Purchase of property, plant and equipment                                         (746,289)         (677,038)       (300,055)
 Purchase of biological assets                                                                                       248,100
 Purchase of other financial assets                                                                                  (141,170)
 Grant funding received                                                            17,728,014        1,397,799       17,066,111
 Cash flows from investing activities                                              9,753,060         703,658         16,931,682

 Cash flows from financing activities
 Proceeds from issuing shares                                                      10,197,528
 Other loans                                                                                                         25,869
 Payments to related parties                                                       227,105           (1,087,917)     62,000
 Loans received related parties                                                                      17,786,900
 Repayments of finance lease                                                       (80,155)          (234,148)       (82,284)
 Cash flows from financing activities                                              10,344,478        16,464,835      5,585

 Net increase in cash and cash equivalents before effect of
 exchange rate changes                                                             20,085,369        6,219,696       13,168,969
 Effect of exchange rate changes on cash and cash equivalents                      (3,398,237)       1,461,509
 Net increase in cash and cash equivalents                                         16,687,132        7,681,205       13,168,969
 Cash and cash equivalents at beginning of the period                              43,704,462        36,023,257      36,023,257
 Cash and cash equivalents at end of the period                                    60,391,594        43,704,462      49,192,226

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NEXEASFKASLLFFA

Recent news on Inqo Investments

See all news